Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network
- 26 February 2007
- journal article
- research article
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 32 (4) , 321-329
- https://doi.org/10.1016/j.jsat.2006.05.021
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugsPharmacology & Therapeutics, 2005
- A multi‐center randomized trial of buprenorphine–naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkAddiction, 2005
- Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field ExperienceThe American Journal on Addictions, 2004
- Clinical efficacy of buprenorphine: comparisons to methadone and placeboDrug and Alcohol Dependence, 2003
- Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.Journal of Consulting and Clinical Psychology, 2002
- Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.Journal of Consulting and Clinical Psychology, 2002
- Give them prizes and they will come: Contingency management for treatment of alcohol dependence.Journal of Consulting and Clinical Psychology, 2000
- Give them prizes and they will come: Contingency management for treatment of alcohol dependence.Journal of Consulting and Clinical Psychology, 2000
- Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence.Journal of Consulting and Clinical Psychology, 2000
- Effects of adding behavioral treatment to opioid detoxification with buprenorphine.Journal of Consulting and Clinical Psychology, 1997